Tech Company Financing Transactions
Spherics Funding Round
Spherics closed a $26.4 million Series C financing round on 5/12/2005. Investors included Advent International, CB Health Ventures and Mitsubishi Corporation.
Transaction Overview
Company Name
Announced On
5/12/2005
Transaction Type
Venture Equity
Amount
$26,400,000
Round
Series C
Investors
Advent International (Lead Investor) (Jason Fisherman)
Proceeds Purpose
The proceeds from this financing will be used to advance the Company's pipeline of products based on its proprietary drug delivery technologies, as well as enhance its commercialization and business development capabilities.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
375 Forbes Blvd.
Mansfield, MA 02048
USA
Mansfield, MA 02048
USA
Phone
Website
Email Address
Overview
Spherics is an emerging pharmaceutical company focused on developing proprietary oral products with improved therapeutic profiles for treatment of Central Nervous System (CNS) disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Poole
VP - Administration
Michael Gattoni
VP - R & D
Avinash Nangia
VP - Regulatory Affairs
Mark Iampietro
Browse more venture capital transactions:
Prev: 5/12/2005: Ambit Biosciences venture capital transaction
Next: 5/12/2005: InnerPulse venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs